メセナミン市場- 世界の産業規模、シェア、動向、機会、予測、用途別、販売チャネル別、地域別、競争別、2020～2035年

世界のメセナミン市場は、2024年には50万2,720トンとなり、2035年には74万940トンに達すると予測され、予測期間中の年間平均成長率（CAGR）は3.59％を記録します。

メセナミンの世界市場力学はダイナミックであり、様々な産業における幅広い用途が市場を牽引しています。ヘキサメチレンテトラミンとしても知られるメセナミンは、医薬品、プラスチック、消毒剤として広く使用されています。医薬品セグメントでは、尿路感染症（UTI）の治療に重要な役割を果たし、特定の細菌株と闘う抗菌性を発揮します。世界保健機関（WHO）の報告書によると、細菌感染症における一般的な抗生物質に対する耐性が強まっていることが、需要の増加に寄与しています。性感染症の主要原因である淋菌分離株の60％以上が、広く使用されている抗生物質であるシプロフロキサシンに耐性を示しています。さらに、尿路結石の主要原因である大腸菌分離株の20％以上が、第一選択薬（アンピシリン、コトリモキサゾール）と第二選択薬（フルオロキノロン）の両方の治療に耐性を示しています。

主要市場促進要因

医薬品用途におけるメセナミンの需要拡大

主要市場課題

規制上のハードルとコンプライアンスの問題

主要市場動向

メセナミン生産における技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のメセナミン市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別（合成樹脂、ゴム産業、繊維産業、その他）
  • 販売チャネル別（直接販売と間接販売）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米のメセナミン市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州のメセナミン市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋のメセナミン市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米のメセナミン市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのメセナミン市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収（該当する場合）
• 製品の発売（該当する場合）

第13章 ポーターのファイブフォース分析

• 産業内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Shandong Shengxuelong Chemical Co., Ltd.
• UCC Shchekinoazot
• Sina Chemical Industries Company
• Henan Runhua Chemicals Co.,Ltd
• Guangzhou Hanpu Pharmaceutical Co Ltd
• Zaozhuang xudong chemical technology co., ltd.
• Simalin Chemical Industries Private Limited

第15章 戦略的提言

第16章 調査会社について・免責事項

The global Methenamine market was valued at 502.72 thousand tonnes in 2024 and is projected to reach 740.94 thousand tonnes by 2035, registering a Compound Annual Growth Rate (CAGR) of 3.59% over the forecast period.

The global Methenamine market is dynamic and driven by its broad range of applications across various industries. Methenamine, also known as hexamethylenetetramine, is widely used in pharmaceuticals, plastics, and as a disinfectant. In the pharmaceutical sector, it plays a critical role in treating urinary tract infections (UTIs), offering antimicrobial properties that combat specific bacterial strains. According to a World Health Organization (WHO) report, the growing resistance to common antibiotics in bacterial infections is contributing to increased demand. Over 60% of Neisseria gonorrhoeae isolates, a major cause of sexually transmitted infections, have shown resistance to ciprofloxacin, a widely used antibiotic. Additionally, more than 20% of E. coli isolates, a leading cause of UTIs, demonstrate resistance to both first-line (ampicillin, co-trimoxazole) and second-line (fluoroquinolones) treatments.

Key Market Drivers

Growing Demand for Methenamine in Pharmaceutical Applications

One of the main drivers of the global Methenamine market is its increasing use in the pharmaceutical industry, especially for its antimicrobial properties in treating UTIs. As UTIs remain one of the most common bacterial infections worldwide, the rising prevalence of these infections, particularly among women and the elderly, is fueling demand for Methenamine-based treatments. Methenamine is highly effective at preventing bacterial growth in the urinary tract and is frequently prescribed in combination with other drugs to enhance its therapeutic effects. In September 2024, Mankind Pharma Ltd. introduced its RAPID NEWS self-test kits to address prevalent health concerns such as UTIs, dengue, and early menopause. This innovation aims to make healthcare more accessible by offering individuals across India a convenient, private, and rapid testing solution.

Key Market Challenges

Regulatory Hurdles and Compliance Issues

The global Methenamine market faces significant regulatory challenges, which may hinder its growth. Methenamine, due to its classification as a chemical compound with multiple industrial applications, is subject to stringent regulations across different countries. These regulations primarily focus on safety standards, environmental impact, and potential risks to human health. Governments in regions such as the European Union, North America, and Asia Pacific have imposed limits on the manufacturing and use of chemicals like Methenamine due to concerns over their toxicity and environmental effects. Companies in this sector must navigate complex regulatory frameworks, including safety certifications, environmental approvals, and product registrations, which can delay time-to-market and increase operational costs. Additionally, the evolving nature of regulatory policies and the potential introduction of new laws add uncertainty to the market landscape.

Key Market Trends

Technological Advancements in Methenamine Production

Technological innovations in Methenamine production are driving the expansion of the global market. As demand for Methenamine grows across various industries, more efficient and cost-effective manufacturing processes are essential to meet market needs. New advancements in production technologies, such as sustainable manufacturing methods and improved reaction conditions, have significantly reduced production costs and increased output. This has made Methenamine more accessible to industries requiring large quantities of the compound.

Key Market Players

• Shandong Shengxuelong Chemical Co., Ltd.
• UCC Shchekinoazot
• Sina Chemical Industries Company
• Henan Runhua Chemicals Co., Ltd.
• Guangzhou Hanpu Pharmaceutical Co. Ltd
• Zaozhuang Xudong Chemical Technology Co., Ltd.
• Simalin Chemical Industries Private Limited

Report Scope

This report segments the Global Methenamine Market into the following categories, along with detailed insights into industry trends:

Methenamine Market by End-Use:

• Synthetic Resin
• Rubber Industry
• Textile Industry
• Other Industries

Methenamine Market by Sales Channel:

• Direct Sales
• Indirect Sales

Methenamine Market by Region:

• North America: United States, Canada, Mexico
• Europe: France, United Kingdom, Italy, Germany, Spain
• Asia-Pacific: China, India, Japan, Australia, South Korea
• South America: Brazil, Argentina, Colombia
• Middle East & Africa: South Africa, Saudi Arabia, UAE

Competitive Landscape

Company Profiles: In-depth analysis of the leading companies operating in the Global Methenamine Market.

Available Customizations:

The Global Methenamine Market report can be customized based on specific company needs. Customization options include:

• Company Information: Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Methenamine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By End-Use (Synthetic Resin, Rubber Industry, Textile Industry, and Others)
  • 5.2.2. By Sales Channel (Direct Sale and Indirect Sale)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Methenamine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By End-Use
  • 6.2.2. By Sales Channel
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Methenamine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By End-Use
      • 6.3.1.2.2. By Sales Channel
  • 6.3.2. Mexico Methenamine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By End-Use
      • 6.3.2.2.2. By Sales Channel
  • 6.3.3. Canada Methenamine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By End-Use
      • 6.3.3.2.2. By Sales Channel

7. Europe Methenamine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By End-Use
  • 7.2.2. By Sales Channel
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Methenamine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By End-Use
      • 7.3.1.2.2. By Sales Channel
  • 7.3.2. Germany Methenamine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By End-Use
      • 7.3.2.2.2. By Sales Channel
  • 7.3.3. United Kingdom Methenamine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By End-Use
      • 7.3.3.2.2. By Sales Channel
  • 7.3.4. Italy Methenamine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By End-Use
      • 7.3.4.2.2. By Sales Channel
  • 7.3.5. Spain Methenamine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By End-Use
      • 7.3.5.2.2. By Sales Channel

8. Asia-Pacific Methenamine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By End-Use
  • 8.2.2. By Sales Channel
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Methenamine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By End-Use
      • 8.3.1.2.2. By Sales Channel
  • 8.3.2. India Methenamine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By End-Use
      • 8.3.2.2.2. By Sales Channel
  • 8.3.3. South Korea Methenamine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By End-Use
      • 8.3.3.2.2. By Sales Channel
  • 8.3.4. Japan Methenamine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By End-Use
      • 8.3.4.2.2. By Sales Channel
  • 8.3.5. Australia Methenamine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By End-Use
      • 8.3.5.2.2. By Sales Channel

9. South America Methenamine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By End-Use
  • 9.2.2. By Sales Channel
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Methenamine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By End-Use
      • 9.3.1.2.2. By Sales Channel
  • 9.3.2. Argentina Methenamine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By End-Use
      • 9.3.2.2.2. By Sales Channel
  • 9.3.3. Colombia Methenamine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By End-Use
      • 9.3.3.2.2. By Sales Channel

10. Middle East and Africa Methenamine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By End-Use
  • 10.2.2. By Sales Channel
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Methenamine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By End-Use
      • 10.3.1.2.2. By Sales Channel
  • 10.3.2. Saudi Arabia Methenamine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By End-Use
      • 10.3.2.2.2. By Sales Channel
  • 10.3.3. UAE Methenamine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By End-Use
      • 10.3.3.2.2. By Sales Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Shandong Shengxuelong Chemical Co., Ltd.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. UCC Shchekinoazot
• 14.3. Sina Chemical Industries Company
• 14.4. Henan Runhua Chemicals Co.,Ltd
• 14.5. Guangzhou Hanpu Pharmaceutical Co Ltd
• 14.6. Zaozhuang xudong chemical technology co., ltd.
• 14.7. Simalin Chemical Industries Private Limited

15. Strategic Recommendations

16. About Us & Disclaimer